Non-HDL cholesterol (non-HDL-C) is a fraction that can be easily calculated from a traditional lipid panel. The value is strongly associated with an increased risk of heart disease. Over the years, LDL cholesterol (LDL-C) has been the most commonly used lipid variable to predict risk (1)...
中文名称 :非高密度脂蛋白胆固醇(non-high density lipopmtein-cholesterol,非HDL-C)测定试验 英文名称 : 别名: ICD 号:c16.9 原理 非HDL-C是指除HDL以外其他脂蛋白中含有的CHOL的总和,主要包括LDL-C 和VLDL-C,其中LDL-C占70%以上。 临床意义 适用于TG水平在2.27~5.64mmol/L,特别适用于VLDL-C增高、HDL-...
Non-HDL-C and HDL-C ratio PIR: Poverty-to-income ratio BMI: Body mass index TC: Total Cholesterol NCHS: National Center for Health Statistics FNIH: Foundation for the National Institutes of Health RLP-C: Remnant Lipoprotein Cholesterol VLDL: Very Low-Density Lipoprotein LDL: Low-...
1ML01 Non-HDL-C as a risk factor: Emerging evidence with atherogenic apoB-containing lipoproteins (VLDL, IDL, and LDL)doi:10.1016/S1567-5688(03)90075-4J.ChapmanSDOSAtherosclerosis Supplements
Blood lipids such as serum activities of triglyceride (TG), total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), and cholesterol (CHOL). 6. Other secondary outcome might include diamine oxidase (DAO), lipopolysaccharide, D-lactic aci...
Patient-Level Discordance in Population Percentiles of the TC/HDL-C Ratio Compared with LDL-C and Non-HDL-C: The Very Large Database of Lipids Study ( VLDL... et al.Patient-level discordance in population percentiles of the TC/HDL-C ratio compared with LDL-C and Non-HDL-C:the Very La...
(HDL) cholesterol (Supplementary Fig.3e). GM4951 deficiency significantly increased both triglycerides (Supplementary Fig.3f) and FFA (Supplementary Fig.3g) in the liver, with no change in liver cholesterol (Supplementary Fig.3h). To check ifGm4951−/−mice develop NAFLD on a standard chow...
HDL, LDL, and very low-density apolipoprotein (VLDL) levels were measured using the LipoPrint LDL system (LipoPrint LDL Subfraction kit, catalog no. 48-7002; Quantimetrix, Redondo Beach, CA) according to the manufacturer’s instructions. The results from the LipoPrint system are directly quantifi...
Baseline ratios of Tot-chol/HDL were elevated at 4.4–4.6 and there were no changes to these ratios after treatment (Figure 4), suggesting that the HDL-chol decrease was a consequence of decreased Tot-chol levels. ApoB also increased in the placebo group, consistent with elevation of LDL ...